159 related articles for article (PubMed ID: 30373213)
1. Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD Pathology.
Nasaruddin ML; Pan X; McGuinness B; Passmore P; Kehoe PG; Hölscher C; Graham SF; Green BD
Metabolites; 2018 Oct; 8(4):. PubMed ID: 30373213
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies.
Graham SF; Nasarauddin MB; Carey M; McGuinness B; Holscher C; Kehoe PG; Love S; Passmore AP; Elliott CT; Meharg A; Green BD
J Alzheimers Dis; 2015; 44(3):851-7. PubMed ID: 25362038
[TBL] [Abstract][Full Text] [Related]
3. Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS.
Nasaruddin ML; Hölscher C; Kehoe P; Graham SF; Green BD
Am J Transl Res; 2016; 8(1):154-65. PubMed ID: 27069549
[TBL] [Abstract][Full Text] [Related]
4. EEG Characteristics of Dementia With Lewy Bodies, Alzheimer's Disease and Mixed Pathology.
van der Zande JJ; Gouw AA; van Steenoven I; Scheltens P; Stam CJ; Lemstra AW
Front Aging Neurosci; 2018; 10():190. PubMed ID: 30018548
[No Abstract] [Full Text] [Related]
5. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
van der Zande JJ; Steenwijk MD; Ten Kate M; Wattjes MP; Scheltens P; Lemstra AW
Neurobiol Aging; 2018 Nov; 71():171-178. PubMed ID: 30149288
[TBL] [Abstract][Full Text] [Related]
6. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S
PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276
[TBL] [Abstract][Full Text] [Related]
7. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
8. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
[TBL] [Abstract][Full Text] [Related]
11. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
12. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
13. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
14. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
15. Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.
Iseki E
Neuropathology; 2004 Mar; 24(1):72-8. PubMed ID: 15068176
[TBL] [Abstract][Full Text] [Related]
16. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
[TBL] [Abstract][Full Text] [Related]
20. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
Lippa CF; Johnson R; Smith TW
Ann Neurol; 1998 Jan; 43(1):102-6. PubMed ID: 9450774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
